Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | LIPE | Q05469 | 7/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | PPOX | P50336 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.37 |
| ▸ | FPR2 | P25090 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clodinafop SCHEMBL7578921 | 0.87 | SMN1; SMN2 (0.38) | LMNALIPEMEN1KMT2ATTR | |
| Quizalofop SCHEMBL7581249 | 0.86 | LMNA (0.47) | RAB9AMAPTNPSR1LMNAMEN1 | |
| SCHEMBL7585729 | 0.82 | MEN1 (0.38) | MAPTPOLBLMNAMEN1KMT2A | |
| Fenoxaprop SCHEMBL7588818 | 0.82 | PPARG (0.34) | MAPTNPSR1LMNAMEN1KMT2A | |
| Mecoprop SCHEMBL7581550 | 0.80 | TSHR (0.48) | MAPTNPSR1POLBLMNAMEN1 | |
| Diclofop-Methyl SCHEMBL7587639 | 0.79 | TDP1 (0.43) | MAPTLMNAMEN1KMT2ATTR | |
| Acifluorfen SCHEMBL7586484 | 0.78 | MEN1 (0.68) | RAB9AMAPTNPSR1POLBLMNA | |
| Fluazifop SCHEMBL1559717 | 0.77 | LMNA (0.62) | RAB9AMAPTNPSR1LMNALIPE | |
| Fluazifop-P SCHEMBL29370487 | 0.77 | LMNA (0.62) | RAB9AMAPTNPSR1LMNALIPE | |
| Fluazifop-P SCHEMBL118853 | 0.77 | LMNA (0.62) | RAB9AMAPTNPSR1LMNALIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | RAB9A 1914/4885MAPT 1092/4885NPSR1 4306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.